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Background: Maternal near misses occur more often than maternal deaths and could enable more comprehensive
analysis of risk factors, short-term outcomes and prognostic factors of complications during pregnancy and childbirth.
The study determined the incidence, determinants and prognostic factors of severe maternal outcomes (near miss or
maternal death) in two referral hospitals in Uganda.
Methods: A prospective cohort study was conducted between March 1, 2013 and February 28, 2014, where cases of
severe pregnancy and childbirth complications were included. The clinical conditions included abortion-related
complications, obstetric haemorrhage, hypertensive disorders, obstructed labour, infection and pregnancy-specific
complications such as febrile illness, anemia and premature rupture of membranes. Near miss cases were defined
according to the WHO criteria. Multivariate logistic regression analysis was conducted to identify prognostic
factors for severe maternal outcomes.
Results: Of 3100 women with severe obstetric complications, 130 (4.2 %) were maternal deaths and 695 (22.7 %)
were near miss cases. Severe pre-eclampsia was the commonest morbidity (incidence ratio (IR) 7.0 %, case-fatality
rate (CFR) 2.3 %), followed by postpartum haemorrhage (IR 6.7 %, CFR 7.2 %). Uterine rupture (IR 5.5 %) caused
the highest CFR (17.9 %), followed by eclampsia (IR 0.4 %, CFR 17.8 %). The three groups (maternal deaths, near
misses and non-life-threatening obstetric complications) differed significantly regarding gravidity and education
level. The commonest diagnostic criteria for maternal near miss were admission to the high dependency unit
(HDU) or to the intensive care unit (ICU). Thrombocytopenia, circulatory collapse, referral to a more specialized unit,
intubation unrelated to anaesthesia, and cardiopulmonary resuscitation were predictive of maternal death (p < 0.05).
Gravidity (ARR 1.4, 95 % C1 1.0–1.2); elevated serum lactate levels (ARR 4.5, 95 % CI 2.3–8.7); intubation for conditions
unrelated to general anaesthesia (ARR 2.6 (95 % CI 1.2–5.7), cardiovascular collapse (ARR 4.9, 95 % CI 2.5–9.5); transfusion
of 4 or more units of blood (ARR 1.9, 95 % CI 1.1–3.1); being an emergency referral (ARR 2.6, 95 % CI 1.2–5.6); and need
for cardiopulmonary resuscitation (ARR 6.1, 95 % CI 3.2–11.7), were prognostic factors.
Conclusions: The analysis of near misses is a useful tool in the investigation of severe maternal morbidity. The prognostic
factors for maternal death, if instituted, might save many women with obstetric complications.* Correspondence: dankkaye@yahoo.com
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For every maternal death, there are about 100 women with
severe maternal morbidity from life-threatening obstetric
complications, referred to as maternal near misses [1]. A
maternal near miss was defined by the World Health
Organization (WHO) as “a woman who, being close to
death, survives a complication that occurred during preg-
nancy, delivery or up to 42 days after the end of her preg-
nancy” [2]. Assessment of maternal near misses offers
several advantages over assessment of maternal deaths:
maternal near misses are commoner than maternal deaths.
In addition, review of maternal near misses yields useful
information on the pathways that lead to severe morbidity
and death [3]. Furthermore, near miss assessment high-
lights the quality of obstetric care received by those who
survive [3]. Prior to the WHO definition, the estimated in-
cidence of maternal near misses varied in different studies,
ranging from less than 1 per 1000 births to 82 per 1000
live births [4–11], partly as a result of different criteria that
were used in the definition of maternal near miss. The
World Health Organization (WHO) [2] developed a tool
which utilize a combination of clinical signs/symptoms,
management practices or presence of organ-system dys-
function. Maternal mortality represents the tip of an ice-
berg. For each death, many other women survive serious
complications during pregnancy, delivery, or puerperium
that lead to varying degrees of organ-system dysfunction
[2]. In many cases, the causes of maternal death are also
responsible for the cases of severe morbidity [2]. The
WHO tool can therefore evaluate the quality of care pro-
vided to women presenting with severe morbidity.
Conceptually, maternal near misses represent a point
on the continuum where good health and death are the
extreme points [12]. On this continuum, women develop
obstetric complications which could be described as un-
complicated, complicated (not life- threatening), severely
complicated (life-threatening) or fatal [13–15]. Such
individuals may recover, become temporarily or perman-
ently disabled, or die [12]. Three approaches were pro-
posed for definition of maternal near miss: using clinical
features (signs, symptoms or clinical entities such as
eclampsia or uterine rupture) [13]; using management
practices (such as admission to intensive care) [11, 12],
or using criteria of organ/system dysfunction [11]. The
drawback of using the clinical criteria is the definition of
the threshold of severity above which morbidity qualifies
to be a maternal near miss. This threshold is context-
specific as the probability of death depends on both the
woman’s vulnerability to succumb and access to prompt
quality care [1–5]. For instance, in studies from Benin
[16], Uganda [6, 17], Angola [18, 19] and Burkina Faso
[20], postpartum haemorrhage qualified as a maternal
near miss only when additional events such as shock,
blood transfusion or hysterectomy occurred. For studiesthat employed the management-based criteria, hysterec-
tomy, admission to intensive care units [21, 22] and pro-
longed hospitalization [23–29] were the commonest
procedures used [21, 22]. Indicators of severity of blood
loss such as hypovolemia requiring massive blood trans-
fusion, severe anaemia with hypotension (requiring in-
tensive resuscitation) are used to identify maternal near
miss. This criterion relies heavily on availability of man-
agement facilities.
The rationale of using the organ-system dysfunction-
based criteria [11] is that women with such dysfunction
are likely to die unless adequate prompt care is provided.
For instance, obstetric haemorrhage constitutes a mater-
nal near miss through vascular dysfunction (hypovol-
emia, shock and circulatory collapse), renal dysfunction
(oliguria, acute kidney injury, renal failure), or coagula-
tion dysfunction. The criteria rely heavily on availability
of laboratory or other investigation facilities.
While assessment of maternal near miss is increasingly
being recognised as potentially more useful that assess-
ment of maternal mortality, severe maternal morbidity
that constitutes a near miss is much less easy to define
or quantify than maternal death. Studies that assessed
maternal near miss using the WHO criteria recom-
mended that future studies should evaluate the burden
of maternal near miss using several morbidity and mor-
tality indices [30, 31]. These indices include the mater-
nal near miss incidence ratios, the severe maternal
outcome ratio, the case-fatality ratio, the severe maternal
morbidity index, and the maternal mortality ratio. To be
able to reduce mortality in cases of severe maternal mor-
bidity, there is a need to develop criteria for factors that
can easily, uniformly and promptly identify prognostic
factors among women with potentially life-threatening
obstetric complications. There are few published studies
from Africa that have used the WHO for definition of
maternal near miss. Yet the WHO has recommended
investigating near-misses as a benchmark practice for
monitoring the quality of obstetric care and has stan-
dardized the criteria for diagnosis [2]. In addition, little
is published on the burden of the maternal near miss as
evidences by the morbidity severity indicators. The ob-
jective was to determine the incidence, characteristics,
and prognostic factors for severe maternal outcomes
(maternal near miss or maternal death) in two regional
referral hospitals in central Uganda.
Methods
Study setting and design
This was a prospective cohort study of women admitted
with pregnancy complications admitted between March
1, 2013 and February 28, 2014. The study was conducted
at Mulago and Jinja Hospitals. Mulago is Uganda’s na-
tional referral hospital and the teaching hospital for
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of which over 400 are maternity beds, and conducts over
30,000 deliveries per year. Jinja is a large regional referral
hospital that serves about six district hospitals in Central
and Eastern Uganda. It has a capacity of over 900 beds
of which over 200 are maternity beds.
Data collection
Participants were women with obstetric complications. In
the selection criteria, all women with obstetric complica-
tions were enrolled into the study, irrespective of the
severity of complications. Depending on the severity, the
WHO criteria [2] were used to classify survivors of severe
obstetric complications into maternal near miss morbidity
(according to the criteria recommended by the tool), or
those with non-life threatening obstetric complications.
Women who consented to participate were recruited in
the study. Using an interviewer-administered question-
naire, participant examination, investigations and through
review of medical records, data was collected on socio-
demographic characteristics, obstetric history, current
pregnancy complications and pregnancy outcomes up
to the time participants were discharged from hospital
or died. Data for women with no or minor obstetric
complications was excluded from the analysis.
Sample size estimation
Assuming a power of 80 % at the 95 % significance level
and a maximum accepted error of 5 %, and an assumed
incidence ratio of obstetric complications of 15 % of all
women who deliver, and assuming that 50 % of women
with severe obstetric complications would end up as ma-
ternal near misses, our sample size was estimated to be
2600 women with obstetric complications of whom
about 385 would be women with severe obstetric mor-
bidity (near misses).
Data analysis
We computed descriptive characteristics of maternal
near miss, whereby categorical variables were presented
as frequencies and percentages while numerical variables
are presented as means or medians (with standard devia-
tions or inter-quartile ranges respectively). In addition,
we computed the following indicators: i) The maternal
near miss incidence ratios derived as the ratio of near
miss per 1000 live births respectively; ii.) The severe ma-
ternal outcome ratio as ratio of maternal death plus near
misses per 1000 live births; iii) The case-fatality rate for
maternal complications determined as the proportion of
deaths out of the total number of patients presenting
with specific complications, expressed as a percentage;
iv) The severe maternal mortality index, derived as ma-
ternal deaths divided by (total deaths plus maternal near
misses) expressed as a percentage; v) The maternalmortality ratio expressed as all maternal deaths per
100,000 live births as well as the perinatal mortality ratio
expressed as all perinatal deaths per 1000 live births.
Furthermore, we analysed risk factors for severe ma-
ternal outcomes (maternal near miss or maternal death).
Categorical variables were compared with X2 square or
Fisher’s exact test and continuous variables with a two-
tailed Student t test. We further analysed the prognostic
factors of maternal near miss using log binomial regres-
sion analysis, where characteristics of near misses and
maternal deaths were compared and adjusted relative
risks computed. Variables included in the models were
those with a p-value less than or equal to 0.2 or import-
ant from a clinical standpoint. After assessing the effects
of confounding, interaction and collinearity, the final model
contained mainly the laboratory-based and management-
based criteria (for diagnosis of a maternal near miss).Ethical considerations
This research was part of a post-doctoral research pro-
ject of the first author (DKK) entitled: “Evaluation and
surveillance of the impact of maternal and neonatal
near-miss morbidity on the health of mothers and infants
in Jinja and Mulago hospitals”. Ethical approval to con-
duct the study was obtained from the Ethics and research
committees of Mulago hospital (REC 310-2012), the
School of Medicine, Makerere University College of Health
Sciences (REC 2012-172) and from Uganda National
Council for Science and Technology. Permission to con-
duct the study was obtained from the department of Ob-
stetrics and Gynaecology, Makerere University, and from
Mulago National Referral Hospital and Jinja Hospital.
Participants gave written informed consent to be en-
rolled in the study and for their data to be included in the
study. Participants included minors (aged 14-17years), as
Uganda national guidelines for human subject research
[32] allow research on mature and emancipated minors in
certain situations such as in pregnancy, with prior ap-
proval of an institutional review board. For those with very
severe morbidity, consent was obtained retrospectively
when they recovered, or consent was obtained from the
next of kin to involve the patients’ in the study and to in-
clude the patients’ data in our dataset. Participants and
their next of kin received assurances that participation
was voluntary, and that participants were free to stop par-
ticipation at any time without their decision affecting the
care they were entitled to. All those with complications,
and their newborns, were provided free medical care or,
where necessary, were offered additional counselling or re-
ferred to get other support services not available at the
two health facilities. Permission was obtained from the
management of the two referral hospital (and from the
study participants) to review the participants’ records.
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Of the 3100 women with severe obstetric complications,
there were 130 maternal deaths (4.2 %), 695 maternal near
miss cases (22.7 %) and 2275 (73.4 %) women with non-
life threatening obstetric complications (NLTC). In the
same period, there were 25,840 live births. Table 1 shows
the indicators for maternal and perinatal morbidity and
mortality. The main cause was severe pre-eclampsia, with
an incidence of 216 cases (7.0 %), but with a case fatality
rate of only 2.3 %. Postpartum haemorrhage was the sec-
ond main cause of morbidity, contributing to 208 of the
3100 cases (6.7 %) with a case-fatality rate of 7.2 %. How-
ever, uterine rupture caused the highest case-fatality of 27
out of 151 (17.9 %), followed by eclampsia (13 out of 171
or 17.8 %).
Table 2 shows the socio-demographic characteristics
and medical history of the participants, stratified by
severity of complications. The three groups differed sig-
nificantly regarding their gravidity, education level and
timing of the obstetric complications. Table 3 shows the
obstetric complications displayed according to the ma-
ternal outcomes. In relation to the childbirth event, the
most likely time for a mother to develop severe mater-
nal outcomes was if they occurred in the intrapartum
period and continued in the postpartum period (RR 2.5,
95 % CI 1.5–4.2, p-value <0.001); or if complicationsTable 1 Maternal perinatal and neonatal mortality indicators
Indicators Ratio
Maternal near miss ratio 8.42 per 1000 live births.
Severe maternal outcome ratio 9.99 per 1000 live births
Maternal mortality ratio (MMR) 503 per 100,000 live births.
Severe maternal mortality index 15.8 %
Case-specific mortality rates
Puerperal sepsis (9 out of 142) 6.3 %
Severe obstructed labor (19 out of 564) 3.4 %
Abortion-related deaths
Abortion haemorrhage (5 out of 41) 12.2 %
Postabortion sepsis (5 of 114) 4.4 %
Overall (10 out of 155) 6.5 %
Obstetric hemorrhage
Antepartum haemorrhage
(5 out of 136)
5.1 %
Postpartum haemorrhage
(15 out of 208)
7.2 %
Ruptured uterus (27 out of 151) 17.9 %
Hypertensive disorders
Severe preeclampsia (5 out of 216) 2.3 %
Eclampsia (13 out of 171) 17.8 %
HELLP Syndrome (2 out of 7) 28.6 %
Overall (20 out of 394) 5.1 %occurred in the postpartum period (RR 1.8, 95 % CI
1.0–3.0; p-value =0.044).
Table 4 shows the diagnostic criteria used for the defin-
ition of severe maternal outcomes (maternal near miss
cases and maternal deaths) in the 192 women with obstetric
complications. The commonest clinical criteria used to
diagnose severe maternal outcomes were shock (as indi-
cated by very low blood pressure or circulatory collapse and
respiratory rate of more than 40 or less than 6 per minute).
The commonest management-based criteria were admis-
sion to the HDU or ICU, and prolonged hospitalization
longer than 7 days. The commonest laboratory-based cri-
terion was thrombocytopenia (platelet count less than
100,000 per 100 ml). Shock, prolonged comatose state (for
up to 12 h) and circulatory collapse pulse were predictive of
maternal death (p < 0.05). Referral to a more specialized
unit, admission to the HDU or ICU, intubation unrelated
to anaesthesia, and cardiopulmonary resuscitation were
management-based criteria that were predictive of a mater-
nal death (p < 0.05). Laboratory-based diagnostic criteria
were not predictive of maternal death (p > 0.05).
Table 5 shows the prognostic factors for maternal near
miss. Gravidity (ARR 1.1, 95 % C1 1.0–1.2), elevated
serum lactate levels (ARR 4.5, 95 % CI 2.3–8.7), intubation
for conditions unrelated to general anaesthesia (ARR 2.6
(95 % CI 1.2–5.7), cardiovascular collapse(ARR 4.9,
95 % CI 2.5–9.5), transfusion of 4 or more units of blood
(ARR 1.9, 95 % CI 1.1–3.1), being a referral (ARR 2.6,
95 % CI 1.2–5.6), and cardiopulmonary resuscitation
(ARR 6.1, 95 % CI 3.2–11.7) were prognostic factors.
Discussion
The term near-miss describes a serious adverse event
whereby death did not occur either due to luck or prompt
adequate management [33]. This concept was defined by
the World Health Organization (WHO) as “a woman
who, being close to death, survives a complication that oc-
curred during pregnancy, delivery or up to 42 days after
the end of her pregnancy” [2]. The WHO criteria employ
presence of organ dysfunction or a combination of clinical
features, laboratory findings and management practices).
Our results show that the WHO maternal near miss
tool [2] is useful in investigating both maternal morbidity
and the quality of care provided to women with severe ob-
stetric complications. This study is innovative in that it
was conducted in two referral centres (the national refer-
ral and one regional referral hospital), the sample size is
quite large, and the study design was prospective. In
addition, the study used the WHO criteria for definition
of maternal near-miss, and indicators of organ-system
dysfunction were assessed as prognostic factors. In this
study, the WHO tool enabled identification of nearly 7
times more cases of severe morbidity compared to what
assessment of maternal mortality could have yielded.














All patients Maternal deaths Maternal near miss NLTC
Age category 0.447
18 years or less 256 (8.3) 11 (8.5) 57 (8.2) 188 (8.3)
19–24 years 1207 (38.9) 48 (36.9) 251 (36.1) 908 (39.9)
> = 24 years 1637 (52.8) 71 (54.6) 387 (55.7) 1179 (51.7)
Gravidity <0.001
1 999 (32.2) 29 (22.3) 184 (26.5) 786 (34.6)
2–4 1519 (49.0) 62 (47.7) 357 (51.4) 1100 (48.4)
5 and more 582 (18.8) 39 (30.0) 154 (22.2) 389 (17.1)
Marital status 0.249
Single 519 (16.7) 23 (17.7) 134 (19.3) 362 (15.9)
Married 2571 (83.0) 107 (82.3) 560 (80.7) 1904 (83.9)
Separated 10 (0.3) 0 (0.0) 0 (0.0) 10 (0.4)
Employment status 0.053
Formal 304 (9.8) 9 (6.3) 68 (9.8) 228 (10.0)
Informal 994 (32.1) 39 (30.2) 251 (36.2) 704 (31.0)
Unemployed 1797 (58.1) 82 (63.6) 376 (56.0) 1343 (59.0)
ΩEducation level <0.001
None or primary level 1275 (41.4) 72 (56.3) 309 (44.7) 894 (39.5)
Secondary level 1472 (47.8) 49 (38.2) 309 (44.7) 1114 (49.3)
Post-secondary (tertiary) 333 (10.8) 7 (5.5) 75 (10.6) 253 (11.2)
Referral status 0.121
Referred 2064 (66.7) 97 (74.6) 453 (65.3) 1514 (66.6)
Not Referred (self-referrals) 1036 (33.3) 33 (25.4) 242 (34.7) 760 (33.4)
Timing of complications
Occurred before admission 1189 (53.8) 48 (36.9) 324 (46.6) 817 (35.9) <0.001
Occurred before arrival and new
complications developed
565 (25.6) 46 (27.6) 239 (34.4) 290 (12.8)
Complications occurred during hospitalized 458 (20.6) 48 (35.4) 132 (18.9) 1168 (51.3)
Admission to the HDU
Yes 541 (17.5) 71 (54.6) 464 (66.8) 6 (0.3) 0.750
No 2559 (82.5) 59 (45.4) 231 (33.2) 2269 (99.7)
Key: NLTC non-life-threatening obstetric complications
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followed by postpartum haemorrhage. However, uter-
ine rupture caused the highest case-fatality followed by
eclampsia. The commonest diagnostic criteria for ma-
ternal near miss were admission to the high depend-
ency unit (HDU) or to the intensive care unit (ICU).
Gravidity, elevated serum lactate levels, intubation for
conditions unrelated to general anaesthesia, cardiovas-
cular collapse, transfusion of 4 or more units of blood,
being a referral, and need for cardiopulmonary resusci-
tation were prognostic factors.Our finding show no differences on socio-demographic
characteristics (except for education level and gravidity)
and medical history between the three groups (NLTC,
near miss cases and maternal deaths). Therefore, the dif-
ferent clinical causes of morbidity differ only according to
severity of the complications. In addition, the outcomes
may not depend so much on the socio-demographic or
medical history as on the quality of care individuals re-
ceive. The outcome of critically ill patients, such as pa-
tients with severe obstetric complications, is dependent
on clinical and individual factors, previous health status,
Table 3 Obstetric complications in women displayed according to the maternal outcomes
Characteristics Number (percentage) Number (percentage) Number (percentage) Number (percentage) p-value
All patients Maternal deaths Maternal near miss NLTC
N = 3100 N = 130 N = 695 N = 2275
ΩObstetric Haemorrhage <0.001
Antepartum 136 (4.4) 7 (5.4) 82 (11.8) 47 (2.0)
Postpartum 230 (7.4) 35 (26.9) 102 (14.7) 93 (4.0)
Ruptured uterus 154 (5.0) 27 (20.8) 115 (16.5) 12 (0.5)
ΩAbortion-related 0.007
Haemorrhage 41 (1.3) 5 (3.8) 23 (3.3) 13 (0.6)
Postabortion sepsis 8 (0.3) 0 (0.0) 6 (0.9) 2 (0.1)
Septic abortion 20 (0.6) 0 (0.0) 10 (1.4) 10 (0.4)
Hypertensive disorders <0.001
Severe Preeclampsia 218 (7.0) 5 (3.8) 79 (11.4) 134 (6.0)
Eclampsia 172 (5.5) 13 (10) 132 (19.0) 27 (1.2)
Chronic Hypertension 4 (0.1) 0 (0.0) 4 (0.6) 0 (0.0)
HELLP Syndrome 9 (0.3) 2 (1.5) 7 (1.0) 0 (0.0)
Puerperal sepsis 114 (3.7) 14 (10.8) 82 (11.8) 18 (0.8) <0.001
Obstructed labor 564 (18.2) 19 (14.6) 42 (6.0) 503 (22.1) <0.001
Timing of the complications <0.001
&aAntepartum 1431 (48.1) 39 (30.0) 263 (37.8) 1129 (49.6)
Postpartum 156 (5.2) 5 (3.9) 59 (8.5) 92 (4.0)
Intrapartum 571 (19.2) 20 (15.6) 133 (19.1) 418 (18.4)
Antepartum and intrapartum 449 (15.1) 34 (26.1) 91 (13.1) 324 (14.2)
Intrapartum and postpartum 325 (10.9) 27 (20.0) 100 (14.4) 199 (8.8)
Occurred in all three periods 45 (1.5) 6 (4.6) 49 (7.0) 113 (5.0)
∞Mode of delivery <0.001
Vaginal delivery 234 (15.5) 23 (28.4) 115 (21.2) 96 (10.8)
βCaesarean section or laparotomy 1266 (83.8) 56 (69.1) 424 (78.1) 786 (88.7)
Assisted delivery 10 (0.7) 2 (2.5) 4 (0.7) 4 (0.5)
Ω Multiple responses, so percentage does not add up to 100 %; a Antepartum complications include sickle cell anemia, severe asthmatic attack and severe malaria in
pregnancy; & All antenatal and abortion complications included in this group; ∞ Mode of delivery for 1510 women where delivery occurred; β Laparotomy for
ruptured uterus
Nakimuli et al. BMC Pregnancy and Childbirth  (2016) 16:24 Page 6 of 10physiologic reserve, disease severity and adequacy of care
provided [34, 35]. The severity depends on the inherent
risk of disease progression and the quality of care received
in terms of timeliness, adequacy and comprehensiveness.
Since near miss cases share characteristics with maternal
deaths, they may be used to provide information about
hurdles that needed to be overcome after onset of or
worsening of complications. In that way, near misses pro-
vide invaluable information on obstetrical care.
The WHO maternal near miss tool may be used as a
scoring tool for severe obstetric morbidity. The complica-
tions that are unique to pregnancy or childbirth and the
changed physiologic parameters (as a result of pregnancy
changes) make pregnancy, childbirth and the puerperium
unique situations where routinely used scoring systems
for disease severity may be inappropriate or inadequate[35, 36]. Many of the available scoring systems of disease
are not applicable to disease severity in obstetric compli-
cations [34, 35]. Indeed the traditional risk stratification
models used in critically ill non-obstetric patients usually
overestimate mortality among pregnant women, which
makes analysis of morbidity data especially prognostic fac-
tors and their interpretation difficult [36, 37].
The WHO maternal near miss tool is an innovative
concept that could be used to identify prognostic indica-
tors for patients with severe maternal morbidity [37, 38].
Early recognition and prompt management of severe
life-threatening maternal morbidity through improved
access, availability and affordability of critical life-saving
skills and therapeutics is key to reduction of maternal
morbidity and mortality. This calls for tools to assess
prognostic factors in maternal near miss cases.
Table 4 Diagnostic criteria used for the definition of severe maternal outcomes (maternal near miss cases and maternal deaths) in
the 3100 women with obstetric complications (including abortion-related complications)







N (%) N (%) N (%)
ΩClinical criteria
Cyanosis 442 (14.3) 69 (53.1) 370 (53.2) 0.973
Breathing rate more than 40 or less than 6 per minute 521 (16.8) 77 (59.2) 440 (63.3) 0.378
Oliguria poorly or unresponsive to fluids or diuretics 450 (14.8) 62 (47.7) 386 (55.7) 0.093
Loss of consciousness for up to 12 h 268 (8.7) 51 (39.2) 213 (30.6) 0.050
Unconscious (coma) with without recordable pulse 164 (5.3) 43 (33.1) 121 (17.4) <0.001
Gasping due to low PaO2 or pulmonary edema 140 (4.5) 23 (17.7) 117 (17.8) 0.811
aShock as indicated by very low blood pressure or circulatory collapse 606 (19.6) 72 (55.4) 533 (76.4) <0.001
aCoagulation disorders evidenced by low platelets, elevated bleeding
or clotting time, or bleeding tendency
362 (11.7) 50 (38.5) 310 (44.6) 0.195
Cerebrovascular accident 17 (0.6) 5 (3.8) 12 (1.7) 0.118
Paralysis 13 (0.4) 1 (0.8) 12 (1.6) 0.477
ΩLaboratory-based criteria
aBilirubin more than 100 mol/l or more than 6.0 mg/dL 274 (8.8) 44 (33.8) 226 (32.7) 0.792
aThrombocytopenia (less than 100,000) 436 (14.1) 60 (46.2) 373 (53.7) 0.115
Creatinine more than 300 mol/l or more than 3.5 mg/dL 295 (9.5) 47 (36.2) 245 (35.3) 0.844
Elevated lactate 272 (8.8) 40 (30.8) 229 (33.0) 0.626
Low pH less than 7.1 255 (8.3) 31 (24.0) 221 (31.8) 0.071
ΩManagement-based criteria
Oxygen saturation less than 90 % for more than 60 min 499 (16.1) 71 (54.6) 426 (61.3) 0.153
Use of vasoactive drug such as ephedrine 204 (6.6) 36 (27.7) 168 (24.2) 0.393
Dialysis for acute kidney failure 62 (2.0) 13 (10.0) 49 (7.2) 0.242
Peripartum hysterectomy cardiopulmonary 169 (5.5) 12 (9.2) 81 (11.7) 0.423
resuscitation 110 (3.6) 96 (73.8) 619 (88.9) <0.001
aTransfusion more than 4 units of red blood cell concentrate 270 (8.7) 40 (30.8) 225 (32.4) 0.719
aIntubation unrelated to anesthesia 124 (4.1) 32 (24.6) 79 (11.4) <0.001
Admission to the HDU or ICU 541 (17.5) 71 (54.6) 464 (66.8) 0.008
aHospitalization longer than 7 days 537 (17.5) 34 (26.1) 496 (71.4) <0.001
aReturn to operation theatre 67 (2.2) 14 (10.8) 52 (7.4) 0.205
Referral to a more specialized unit 5 (1.5) 16 (14.0) 27 (3.9) <0.001
Major operative non-obstetric surgery 9 (0.3) 2 (1.5) 7 (1.0) 0.592
Ω More than one criterion was manifest in some patients; HDU is the high dependency unit, ICU is Intensive care Unit; a Some patients were among those
with NLTC
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is a validated score used to quantify organ dysfunction
and predict prognosis for severely ill persons admitted to
the ICU [39, 40]. The SOFA score is one of the scoring
systems used to track a patient’s status during the stay in
an ICU where it is used to determine the extent of a per-
son’s organ function or rate of failure. The score is based
on six different scores, one each for the respiratory, car-
diovascular, hepatic, coagulation, renal and neurological
systems. Both the mean and highest SOFA scores arepredictive of mortality outcomes: an increase in SOFA
score during the first 24 to 48 h in the ICU predicts a
mortality rate in 50–95 % of cases [39, 40]. In a study of
obstetric patients admitted to ICU, which compared
scores on the WHO tool and the total maximum Sequen-
tial Organ Failure (SOFA) score as the gold standard, the
WHO near miss criteria had a sensitivity and specificity of
99.2 % and 86.0 % respectively for identification of organ
failure in at least one organ system [39]. In addition, the
WHO tool had a sensitivity of 100 % and specificity
Table 5 Prognostic factors for severe maternal outcomes in women with severe maternal outcomes (maternal deaths plus near misses)
Characteristic Maternal deaths Maternal near
miss morbidity
Crude risk ratios
and 95 % CI
p-values Adjusted
risk ratios
and 95 % CI
p-values
N (%) N (%)
aReferral
Yes 16 (12.3) 27 (28.4) 3.5 2.6
No 114 (87.7) 668 (71.6) (1.8–6.6) <0.001 (1.2–5.6) 0.013
Admission to the ICU or HDU 0.018
Yes 71 (54.6) 464 (66.8) 1.3 0.008 1.9
No 59 (45.4) 231 (33.2) (1.1–2.4) (1.1–3.1)
CPR <0.001
Yes 34 (26.2) 76 (10.9) 2.9 <0.001 6.1
No 96 (73.8) 619 (89.1) (1.8–4.6) (3.2–11.7)
Transfusion more than 4 units 0.013
Yes 40 (30.8) 225 (32.3) 1.9 1.9
No 90 (69.2) 470 (67.7) (1.3–2.7) 0.002 (1.1–3.1)
Cardiovascular collapse 2.9 <0.001
Yes 43(33.1) 121 (17.4) (1.8–4.7) <0.001 4.9
No 87 (66.9) 574 (82.6) (2.5–9.5)
Hypotension <0.001
Yes 72 (55.4) 531 (76.0) 2.6 <0.001 2.6
No 58 (44.6) 164 (24.0) (1.8–3.8) (1.6–4.4)
Intubation <0.001
Yes 31 (31.3) 95 (13.7) 5.0 2.6
No 99 (68.7) 600 (86.3) (3.4–7.6) <0.001 (1.2–5.7)
Elevated serum lactate <0.001
Yes 40 (30.8) 229 (32.9) 1.5 0.078 4.5
No 90 (69.2) 466 (67.1) (0.9–2.4) (2.3–8.7)
βGravidity 0.042
Gravid 1–4 100 (76.9) 541 (77.8) 1.2 0.046 1.1
Gravida 5 or more 30 (23.1) 154 (22.2) (1.1–1.4) (1.0–1.2)
Thrombocytopenia 0.337
Yes 60 (46.1) 373 (53.7) 1.4 0.116 1.4
No 70 (53.9) 322 (46.3) (0.9–1.9) (0.7–3.20
HDU high dependency unit, ICU intensive care unit, RR relative risk, CI confidence intervals, CPR cardiopulmonary resuscitation; a Referral to another unit outside
the obstetric unit; β Comparing gravida 5 or more versus gravida 4 and less; ∞ 68 women died within the first 7 days after admission, and therefore not included
in the analysis
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maximum SOFA score had a good performance (area
under the curve of 0.897) for prediction of cases of mater-
nal near miss according to the WHO criteria [39]. In an-
other study assessing the utility of the SOFA score in
obstetric patients, the total maximum SOFA score was sig-
nificantly higher in women with severe maternal morbidity
(SMM) when compared to that in women without SMM
(p < 0.001) [40]. In addition, the total maximum SOFA
score was predictive of survival by being able to discrimin-
ate pregnant women with SMM who did not survive
(AUROC 0.77, 95 % CI: 0.46, 1.00) [40]. The WHO tool istherefore useful in identification of organ-system dysfunc-
tion and multiple organ failure, which is the final cause of
death in patients with severe obstetric complications.
The analysis of maternal near misses is a useful
innovation in the investigation of severe maternal mor-
bidity [41], though it may require modification in certain
contexts. For instance, in a study conducted in Tanzania
using a modification of the tool [42], 216 maternal near
misses and 32 maternal deaths were identified over a
two year-period. From a hospital based study that used a
modification of the WHO tool [43], the maternal mor-
tality ratio was 350 maternal deaths per 100,000 live
Nakimuli et al. BMC Pregnancy and Childbirth  (2016) 16:24 Page 9 of 10births, the maternal near miss incidence ratio was 23.6
per 1000 live births, and the overall case fatality rate was
12.9 %. The use of the WHO tool underscores the prac-
tical challenges in determining organ-system dysfunction
in obstetric patients. The evidence that the WHO tool
scores fairly well in recognising organ dysfunction and
failure when compared with standard tools such as the
SOFA for assessing organ failure [44, 45], increases its
utility in obstetric patients.
Conclusion
In conclusion, the WHO tool for analysis of maternal
near miss, which uses defined criteria, can identify more
preventable causes of maternal death than the traditional
clinical criteria alone. Prospective monitoring of mater-
nal morbidity may be useful in identifying determinants
and prognostic factors of severe maternal morbidity.
Abbreviations
ARR: adjusted risk ratio; CI: confidence intervals; CPR: cardiopulmonary
resuscitation; HDU: high dependency obstetric unit; HELLP
syndrome: syndrome of hemolysis, elevated liver enzymes and low platelets;
ICU: intensive care unit; NLTC: non-life threatening obstetric complication;
RR: risk ratio; SIDA: Swedish International Development Agency; SMM: severe
maternal morbidity; SOFA: sequential organ failure assessment; WHO: World
Health Organization.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
DKK conceptualized the study the post-doctoral research project of which
this study was a part. OK, MOO, SNM, RCN, AN and SN advised on the design
and data collection. DKK collected the data, led the analysis, and wrote the
text of the paper. All co-authors advised on the data analysis, reviewed and
edited several versions of the drafts and approved the final manuscript.
Acknowledgements
This study was part of a post-doctoral research project for DKK funded by
the Swedish International Development Agency (SIDA) through the Makerere
University-Karolinska Institutet postdoctoral-research grants. The findings and
conclusions of this article are those of the authors and do not necessarily
represent the views of the funders. We are grateful to all women and
newborns who participated in this study.
Author details
1Department of Obstetrics and Gynecology, School of Medicine, College of
Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
2Department of Obstetrics and Gynecology, Jinja Regional Hospital, Jinja,
Uganda. 3Department of Nursing, School of Health Sciences, College of
Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda.
4Clinical, Operations and Health Services Research Program, Joint Clinical
Research Centre, P. O. Box 10005, Kampala, Uganda.
Received: 24 December 2014 Accepted: 21 January 2016
References
1. Report on the World Health Organization working group on the
classification of maternal deaths and severe maternal morbidities. Geneva:
World Health Organization; 2009.
2. Say L, Souza JP, Pattinson RC. Maternal near miss – towards a standard tool
for monitoring quality of maternal health care. Best Pract Res Clin Obstet
Gynecol. 2009;23:287–96.
3. Ronsmans C, Filippi V. Beyond the numbers Reviewing maternal deaths and
complications to make pregnancy safer. Reviewing severe maternalmorbidity and learning from women who survive life threatening
complications. Geneva: World Health Organization; 2004.
4. Adisasmita A, Deviany PE, Nandiaty F, Stanton C, Ronsmans C. Obstetric
near-miss and deaths in public and private hospitals in Indonesia.
BMC Pregnancy Childbirth. 2008;8:10.
5. Souza JP, Cecatti JG, Parpinelli MA, de Sousa MH, Serruya SJ. Systematic
review of near miss maternal morbidity. Cad Saude Publica.
2006;22:255–64.
6. Minkauskien M, Nadisauskiene R, Padaiga Z, Makari S. Systematic review on
the incidence and prevalence of severe maternal morbidity. Medicina.
2004;40:299–309.
7. Okong P, Byamugisha J, Mirembe F, Byaruhanga R, Bergstrom S. Audit of
severe maternal morbidity in Uganda-implications for quality of care. Acta
Obstet Gynecol Scand. 2006;85:797–804.
8. Souza JP, Cecatti JG, Parpinelli MA, Serruya SJ, Amaral E. Appropriate criteria
for identification of near-miss maternal morbidity in tertiary care facilities: a
cross sectional study. BMC Pregnancy Childbirth. 2007;7:20.
9. Gandhi MN, Welz T, Ronsmans C. An audit of life-threatening maternal
morbidity in rural South Africa using ‘near-miss’ criteria adapted for primary
level hospitals. Int J Gynecol Obstet. 2004;87:180–7.
10. Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe
obstetric morbidity: case-control study. BMJ. 2001;322(7294):1089–94.
11. Mantel GD, Buchmann E, Rees H, Pattinson RC. Severe acute maternal
morbidity: a pilot study of a definition for a near-miss. Br J Obstet Gynecol.
1998;105(9):985–90.
12. Geller SE, Rosenberg D, Cox SM, Brown ML, Simonson L, Driscoll CA, et al.
The continuum of maternal morbidity and mortality: factors associated with
severity. Am J Obstet Gynecol. 2004;191(3):939–44.
13. Stones W, Lim W, Al-Azzawi F, Kelly M. An investigation of maternal
morbidity with identification of life threatening ‘near miss’ episodes. Health
Trends. 1991;23(1):13–5.
14. Glazener CM, Abdalla M, Stroud P, Naji S, Templeton A, Russell IT. Postnatal
maternal morbidity: extent, causes, prevention and treatment. Br J Obstet
Gynaecol. 1995;102:282–7.
15. Waterstone M, Wolfe C, Hooper R, Bewley S. Postnatal morbidity after
childbirth and severe obstetric morbidity. BJOG. 2003;110:128–33.
16. Filippi V, Alihonou E, Mukantaganda S, Graham WJ, Ronsmans C. Near
misses: maternal morbidity and mortality. Lancet. 1998;351(9096):145–6.
17. Kaye D, Mirembe F, Aziga F, Namulema B. Maternal mortality and associated
near-misses among emergency intrapartum obstetric referrals in Mulago
Hospital, Kampala, Uganda. East Afr Med J. 2003;80(3):144–9.
18. Strand RT, Campos PA, Paulsson G, de Oliveira J, Bergström S. Audit of
referral of obstetric emergencies in Angola: a tool for assessing quality care.
Afr J Reprod Health. 2009;13:75–85.
19. Strand RT, Tumba P, Niekowal J, Bergström S. Audit of cases with uterine
rupture: a process indicator of quality of obstetric care in Angola. Afr J
Reprod Health. 2010;14(2):55–62.
20. Filippi V, Ronsmans C, Gohou V, Goufodji S, Lardi M, Sahel A, et al. Maternity
wards or emergency obstetric rooms? Incidence of near-miss events in
African hospitals. Acta Obstet Gynecol Scand. 2005;84(1):11–6.
21. Baskett TF, Sternadel J. Maternal intensive care and near-miss mortality in
obstetrics. Br J Obstet Gynecol. 1998;105(9):981–4.
22. Pattinson RC, Say L, Makin JD, Bastos MH. Critical incident audit and
feedback to improve perinatal and maternal mortality and morbidity.
Cochrane Database Syst Rev. 2005;4:CD002961.
23. Amata AO. Anaesthetic and intensive care management of rupture of the
gravid uterus: a review of 50 cases. Trop Doct. 1998;28(4):214–7.
24. Fawzi HW, Kamil KK, Stronge J. Rupture of the uterus in labour: a review of
14 cases in general hospital. J Obstet Gynecol. 1998;18:429–30.
25. Oladapo OT, Ariba AJ, Odusoga OL. Changing patterns of emergency
obstetric care at a Nigerian University hospital. Int J Gynecol Obstet.
2007;98(3):278–84.
26. Oladapo OT, Sule-Odu AO, Olatunji OA, Daniel OJ. “Near-miss” obstetric
events and maternal deaths in Sagamu, Nigeria: a retrospective study.
Reprod Health. 2005;2:9.
27. Prual A, Bouvier-Colle MH, de Bernis L, Breart G. Severe maternal morbidity
from obstetric causes in West Africa: incidence and case fatality rates.
Bull WHO. 2000;78(5):593–602.
28. Prual A, Huguet D, Garbin O, Rabe G. Severe obstetric morbidity of the third
trimester, delivery and early puerperium in Niamey (Niger). Afr J Reprod
Health. 1998;2(1):10–9.
Nakimuli et al. BMC Pregnancy and Childbirth  (2016) 16:24 Page 10 of 1029. Kaye DK, Kakaire O, Osinde MO. Maternal morbidity and near-miss mortality
among women referred for emergency obstetric care in rural Uganda. Int J
Gynaecol Obstet. 2011;114:84–5.
30. Haddad SM, Cecatti JG, Souza JP, Sousa MH, Parpinelli MA, Costa ML.
Applying the maternal near miss approach for the evaluation of quality of
obstetric care: a worked example from a multicenter surveillance study.
Biomed Res Int. 2014;2014:989815.
31. Souza JP, Cecatti JG, Haddad SM, Parpinelli MA, Costa ML, Katz L. The WHO
maternal near-miss approach and the maternal severity index model (MSI):
tools for assessing the management of severe maternal morbidity. PLoS
One. 2012;7(8):e44129.
32. Uganda National Council for Science and Technology (UNCST). National
guidelines for research involving humans as research participants; July 2014.
Kampala: UNCST. p.16-22 http://www.uncst.go.ug/dmdocuments/
Human%20Subjects%20Protection%20Guidelines%20July%202014.pdf
33. Nashef SA. What is a near miss? Lancet. 2003;361(9352):180–1.
34. Strand K, Flaatten H. Severity scoring in the ICU: a review. Acta Anaesthesiol
Scand. 2008;52(4):467–78.
35. Higgins TL. Quantifying risk and benchmarking performance in the adult
intensive care unit. J Intensive Care Med. 2007;22(3):141–56.
36. Lapinsky SE, Hallett D, Collop N, Drover J, Lavercombe P, Leeman M, et al.
Evaluation of standard and modified severity of illness scores in the
obstetric patient. J Crit Care. 2011;26(5):535. e1–e7.
37. Lotufo FA, Parpinelli MA, Haddad SM, Surita FG, Cecatti JG. Applying the
new concept of maternal near-miss in an intensive care unit. Clinics.
2012;67(3):225–30.
38. Cecatti JG, Souza JP, Parpinelli MA, Haddad SM, Camargo RS, Pacagnella RC,
et al. Brazilian network for the surveillance of maternal potentially life
threatening morbidity and maternal near-miss and a multidimensional
evaluation of their long term consequences. Reprod Health. 2009;6:15.
39. Cecatti JG, Souza JP, Oliveira Neto AF, Parpinelli MA, Sousa MH, Say L, et al.
Pre-validation of the WHO organ dysfunction based criteria for identification
of maternal near miss. Reprod Health. 2011;8:22.
40. Kallur DS, Bada VP, Reddy P, Pandya S, Nirmalan PK. Dysfunction and organ
failure as predictors of outcomes of severe maternal morbidity in an
obstetric intensive care unit. J Clin Diagn Res. 2014;8(4):6–8.
41. Jayaratnam S, De Costa C, Howat P. Developing an assessment tool for
maternal morbidity near miss – a prospective study in a large Australian
regional hospital. ANZJOG. 2011;51(5):421.
42. Nelissen E, Mduma E, Broerse J, Ersdal H, Evjen-Olsen B, van Roosmalen J,
et al. Applicability of the WHO maternal near miss criteria in a low-resource
setting. PLoS One. 2013;8(4):e61248.
43. Nelissen EJ, Mduma E, Ersdal HL, Evjen-Olsen B, van Roosmalen JJ,
Stekelenburg J. Maternal near miss and mortality in a rural referral hospital
in northern Tanzania: a cross-sectional study. BMC Pregnancy Childbirth.
2013;13:141.
44. Moreno R, Vincent JL, Matos R, Mendonça A, Cantraine F, Thijs L, et al.
The use of maximum SOFA score to quantify organ dysfunction/failure in
intensive care. Results of a prospective, multicenter study. Intensive Care
Med. 1999;25:686–96.
45. Vincent J-L, De Mendonça A, Cantraine F, Moreno R, Takala J, Suter PM,
et al. Use of the SOFA score to assess the incidence of organ dysfunction/
failure in intensive care units: results of a multicentric, prospective study.
Working group on “sepsis-related problems” of the European Society of
Intensive Care Medicine. Crit Care Med. 1998;26:1783–00.•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
